H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure. Census population 200,603. Alabama Medicare wound biologics: Palmetto GBA (JJ). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Montgomery clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Montgomery storefront.
361 HCT/P Compliant Tissue Products in Montgomery, AL for clinics & physicians. Exclusively 361 HCT/P comp… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of 361 hctp compliant products in Montgomery: (1) CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure. (2) Alabama Part B wound biologics are reviewed by Palmetto GBA under JJ, shared with GA, TN. We help with the second file. We do not pretend to be a Montgomery storefront.
National 361 HCT/P Compliant Tissue Products notes (how the product actually works)11% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 200,603 residents will still mix those payers. CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure. Adult arthritis here is 29.7% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Montgomery.
CDC PLACES (2023, crude prevalence) estimates 16.7% of adults — 4.7 points above the U.S. 12% figure. Obesity is 46.4%; arthritis is 29.7%. That is place-level BRFSS modeling, not a clinic census and not a Montgomery trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Regulatory lane, storage, and JJ coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
No. Palmetto GBA writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
Bring specialty, monthly joint / regenerative volume, and whether you bill JJ FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 16.7% diabetes and 29.7% arthritis for Montgomery — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Montgomery, AL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Montgomery is JJ geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Montgomery — 4.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Alabama Part B wound biologics follow this contractor (siblings: GA, TN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Montgomery. Useful for joint-program math; still needs a diagnosis and privileging.
No Montgomery storefront. Joe Bradley is an active practice owner. 361 hctp compliant products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.